On this page:Overview Publications Researchers Institutions Open access

PICO Portalanswers from OpenAlex

Oklahoma State University Oklahoma City

InstitutionResearch output, impact & collaborations

Oklahoma State University Oklahoma City is a institution indexed in PICO Portal from OpenAlex.

What is known about Oklahoma State University Oklahoma City?

PICO Portalrecord summary

Oklahoma State University Oklahoma City is a research organisation in Oklahoma City, US. OpenAlex records 18,271 works and 438,822 citations for it. 3,862 researchers list it as their most recent affiliation.

How many works does Oklahoma State University Oklahoma City have?

PICO Portalindexed works

Oklahoma State University Oklahoma City has 18,271 works in the PICO Portal index. The count is the OpenAlex total, not the number of papers listed on this page.

See the works listed for Oklahoma State University Oklahoma City →

How many citations does Oklahoma State University Oklahoma City have?

PICO Portalcitation count

Oklahoma State University Oklahoma City has 438,822 citations in the OpenAlex counts PICO Portal stores.

See the listed works for Oklahoma State University Oklahoma City →

How many researchers are at Oklahoma State University Oklahoma City?

PICO Portalresearcher count

Oklahoma State University Oklahoma City has 3,862 researchers in the PICO Portal index.

See the researchers listed on this page →

What is the average h-index at Oklahoma State University Oklahoma City?

PICO Portalavg h-index

Oklahoma State University Oklahoma City has an average h-index of 73.4 in OpenAlex.

Open the OpenAlex record →

What is the ROR of Oklahoma State University Oklahoma City?

PICO Portalror

The ROR for Oklahoma State University Oklahoma City is on the source record.

Open the ROR →

What is the OpenAlex record for Oklahoma State University Oklahoma City?

PICO Portalopenalex

The OpenAlex for Oklahoma State University Oklahoma City is on the source record.

Open the OpenAlex →

Who are the most-cited researchers behind Oklahoma State University Oklahoma City?

PICO Portaltop researchers by citations

Robert S. Mannel · Ovarian cancer diagnosis and treatment

391 works51,813 citations

G. A. Stewart · Particle physics theoretical and experimental studies

341 works36,847 citations

William Jones · Crystallization and Solubility Studies

957 works31,337 citations

G. A. Stewart · Particle physics theoretical and experimental studies

282 works22,407 citations

A. Khanov · Particle physics theoretical and experimental studies

311 works20,129 citations

What are the most-cited papers on Oklahoma State University Oklahoma City?

PICO Portalmost cited works

Incorporation of Bevacizumab in the Primary Treatment of Ovarian Cancer

Robert A. Burger, Mark F. Brady, Michael A. Bookman, Gini F. Fleming, Bradley J. Monk, Helen Huang, Robert S. Mannel, Howard D. Homesley, Jeffrey M. Fowler, Benjamin E. Greer, Matthew Boente, Michael J. Birrer, Sharon X. Liang

New England Journal of Medicine. 20112,398 CitationsOPEN ACCESS

Phase III Trial of Carboplatin and Paclitaxel Compared With Cisplatin and Paclitaxel in Patients With Optimally Resected Stage III Ovarian Cancer: A Gynecologic Oncology Group Study

Robert F. Ozols, Brian N. Bundy, Benjamin E. Greer, Jeffrey M. Fowler, Daniel L. Clarke‐Pearson, Robert A. Burger, Robert S. Mannel, Koen DeGeest, Ellen M. Hartenbach, Rebecca N. Baergen

Journal of Clinical Oncology. 20032,059 Citations

Inherited Mutations in Women With Ovarian Carcinoma

Barbara M. Norquist, Maria I. Harrell, Mark F. Brady, Tom Walsh, Ming K. Lee, Süleyman Gülsüner, Sarah S. Bernards, Silvia Casadei, Yi Qian, Robert A. Burger, John K. Chan, Susan A. Davidson, Robert S. Mannel, Paul DiSilvestro, Heather A. Lankes, Nilsa C. Ramirez, Mary‐Claire King, Elizabeth M. Swisher, Michael J. Birrer

JAMA Oncology. 2015771 CitationsOPEN ACCESS

Pembrolizumab plus Chemotherapy in Advanced Endometrial Cancer

Ramez N. Eskander, Michael W. Sill, Lindsey Beffa, Richard G. Moore, Joanie M. Hope, Fernanda Musa, Robert S. Mannel, Mark S. Shahin, Guilherme Cantuaria, Eugenia Girda, Cara Mathews, Juraj Kavecansky, Charles A. Leath, Lilian T. Gien, Emily Hinchcliff, Shashikant Lele, Lisa M. Landrum, Floor Backes, Roisin E. O’Cearbhaill, Tareq Al Baghdadi, Emily K. Hill, Premal H. Thaker, Veena S. John, Stephen Welch, Amanda N. Fader, Matthew A. Powell, Carol Aghajanian

New England Journal of Medicine. 2023733 CitationsOPEN ACCESS

Bevacizumab and paclitaxel–carboplatin chemotherapy and secondary cytoreduction in recurrent, platinum-sensitive ovarian cancer (NRG Oncology/Gynecologic Oncology Group study GOG-0213): a multicentre, open-label, randomised, phase 3 trial

Robert L. Coleman, Mark F. Brady, Thomas J. Herzog, Paul Sabbatini, Deborah K. Armstrong, Joan L. Walker, Byoung‐Gie Kim, Keiichi Fujiwara, Krishnansu S. Tewari, David M. O’Malley, Susan A. Davidson, Stephen C. Rubin, Paul DiSilvestro, Karen Basen‐Engquist, Helen Huang, John K. Chan, Nick M. Spirtos, Raheela Ashfaq, Robert S. Mannel

The Lancet Oncology. 2017608 CitationsOPEN ACCESS

How much of the research on Oklahoma State University Oklahoma City is open access?

PICO Portalopen access share

83%OPEN ACCESS

Gold

Green

50%

Hybrid

Bronze

33%

Closed

17%